{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:34:12Z","timestamp":1787027652933,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Lymphedema is a condition resulting from mutations in various genes essential for lymphatic development and function, which leads to obstruction of the lymphatic system. Secondary lymphedema is a progressive and incurable condition, most often manifesting after surgery for breast cancer. Although its causation appears complex, various lines of evidence indicate that genetic predisposition may play a role. Previous studies show that mutations in connexin 47 are associated with secondary lymphedema. We have tested the hypothesis that connexin 37 gene mutations in humans are associated with secondary lymphedema following breast cancer surgery. A total of 2211 breast cancer patients were screened and tested for reference single nucleotide polymorphisms (SNPs) of the GJA4 gene (gap junction protein alpha 4 gene). The results presented in this paper indicate that two SNPs in the 3\u2019 UTR (the three prime untranslated region) of the GJA4 gene are associated with an increased risk of secondary lymphedema in patients undergoing breast cancer treatment. Our results provide evidence of a novel genetic biomarker for assessing the predisposition to secondary lymphedema in human breast cancer patients. Testing for the condition-associated alleles described here could assist and inform treatment and post-operative care plans of breast cancer patients, with potentially positive outcomes for the management of disease progression.<\/jats:p>","DOI":"10.3390\/biomedicines6010023","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T07:05:41Z","timestamp":1519283141000},"page":"23","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["GJA4\/Connexin 37 Mutations Correlate with Secondary Lymphedema Following Surgery in Breast Cancer Patients"],"prefix":"10.3390","volume":"6","author":[{"given":"Mahrooyeh","family":"Hadizadeh","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran"},{"name":"Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan 81746753461, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiied","family":"Mohaddes Ardebili","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Salehi","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan 81746753461, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Young","sequence":"additional","affiliation":[{"name":"School of Allied Health Sciences, Faculty of Health and Life Sciences, De Montfort University, Leicester LE1 9BH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Mokarian","sequence":"additional","affiliation":[{"name":"Cancer Prevention Research Centre, Isfahan University of Medical Sciences, Isfahan 8184917911, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McClellan","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Portsmouth, Portsmouth PO1 2DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health and Life Sciences, De Montfort University, Leicester LE1 9BH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kazemi","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan 81746753461, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Moazam","sequence":"additional","affiliation":[{"name":"Cancer Prevention Research Centre, Isfahan University of Medical Sciences, Isfahan 8184917911, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-6971","authenticated-orcid":false,"given":"Behzad","family":"Mahaki","sequence":"additional","affiliation":[{"name":"Department of Occupational Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Bonab","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Chester, Chester CH1 4BJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2362.2010.02378.x","article-title":"Mutations in connexin genes and disease","volume":"41","author":"Pfenniger","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/ars.2008.2128","article-title":"Connexin-caused genetic diseases and corresponding mouse models","volume":"11","author":"Dobrowolski","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev.cellbio.19.111301.144309","article-title":"Connexins and cell signalling in development and disease","volume":"20","author":"Wei","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tcb.2009.11.001","article-title":"The gap junction proteome and its relationship to disease","volume":"20","author":"Laird","year":"2010","journal-title":"Trends Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1188\/08.CJON.951-964","article-title":"Demystifying lymphedema: Development of the lymphedema putting evidence into practice card","volume":"12","author":"Poage","year":"2008","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1086\/316915","article-title":"Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema distichiasis syndrome","volume":"67","author":"Fang","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1200\/JCO.2007.14.4899","article-title":"Lymphedema after breast cancer: Incidence, risk factors, and effect on upper body function","volume":"26","author":"Hayes","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1524-4741.2006.00342.x","article-title":"Breast cancer related lymphedema\u2014What are the significant predictors and how they affect the severity of lymphedema?","volume":"12","author":"Soran","year":"2006","journal-title":"Breast J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/lrb.2008.1524","article-title":"HGF and MET mutations in primary and secondary lymphedema","volume":"6","author":"Finegold","year":"2008","journal-title":"Lymphat. Res. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1158\/1078-0432.CCR-11-2303","article-title":"Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment","volume":"18","author":"Finegold","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1212\/01.wnl.0000284828.84464.35","article-title":"GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease","volume":"70","author":"Henneke","year":"2008","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/brain\/awn328","article-title":"Hereditary spastic paraplegia is a novel phenotype for GJA12\/GJC2 mutations","volume":"132","author":"Salsano","year":"2009","journal-title":"Brain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0975-3583.89804","article-title":"Evaluating the role of connexin43 in congenital heart disease: Screening for mutations in patients with outflow tract anomalies and the analysis of knock-in mouse models","volume":"2","author":"Huang","year":"2011","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1152\/physrev.00007.2003","article-title":"Plasma membrane channels formed by connexins: Their regulation and functions","volume":"83","author":"Saez","year":"2003","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/ATVBAHA.109.200816","article-title":"Gap junction protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells","volume":"30","author":"Pfenniger","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa021445","article-title":"Prediction of the risk of myocardial infarction from polymorphisms in candidate genes","volume":"347","author":"Yamada","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_17","unstructured":"International Society of Lymphology (2013). The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology, 46, 1\u201311."},{"key":"ref_18","unstructured":"GeNet Bio (2014, August 03). PrimePrep Genomic DNA Isolation Kit Manual from Blood and Tissue. Available online: www.genetbio.com\/en\/page9.html."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/14622416.8.6.597","article-title":"High-resolution DNA melting analysis for simple and efficient molecular diagnostics","volume":"8","author":"Reed","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajhg.2010.04.010","article-title":"GJC2 missense mutations cause human lymphedema","volume":"86","author":"Ferrell","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.2010.085563","article-title":"Rapid identification of mutations in GJC2 in primary lymphoedema using whole exome sequencing combined with linkage analysis with delineation of the phenotype","volume":"48","author":"Ostergaard","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_22","first-page":"558","article-title":"Regulation of Connexins Expression Levels by MicroRNAs, an Update","volume":"7","author":"Retamal","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Miaskowski, C., Dodd, M., Paul, S.M., West, C., Hamolsky, D., Abrams, G., Cooper, B.A., Elboim, C., Neuhaus, J., and Schmidt, B.L. (2013). Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060164"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cncr.24174","article-title":"Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: A systematic review and meta-analysis","volume":"115","author":"Sanghani","year":"2009","journal-title":"Cancer"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/6\/1\/23\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:55:49Z","timestamp":1760194549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/6\/1\/23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["biomedicines6010023"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines6010023","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]}}}